Proteasome Inhibitors in the Treatment of Multiple Myeloma

QR Code

Proteasome Inhibitors in the Treatment of Multiple Myeloma

None

Saved in:

Bibliographic Details
Main Authors:	Crawford, Lisa J., Irvine, Alexandra E.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/26499
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New proteasome inhibitors in the management of multiple myeloma
by: S. V. Semochkin
Published: (2019-07-01)

Multiple Myeloma and Dentistry
by: Shah, Ajaz, et al.
Published: (2012)

Targeting the Proteasome in Melanoma
by: Sorolla, Anabel, et al.
Published: (2011)

Regulatory Cells and Multiple Myeloma
by: Raja, Karthick Raja Muthu, et al.
Published: (2012)

Renal Disease in Multiple Myeloma
by: Saydam, Guray, et al.
Published: (2012)

Targeted Inhibition of Multiple Proinflammatory Signalling Pathways for the Prevention and Treatment of Multiple Myeloma
by: Kannaiyan, Radhamani, et al.
Published: (2012)

Stem Cell Mobılızatıon in Multıple Myeloma
by: Bakanay, Şule Mine, et al.
Published: (2012)

Cancer Stem Cells in Multiple Myeloma
by: Ciavarella, Sabino, et al.
Published: (2011)

Proteasome Targeted Therapies in Rheumatoid Arthritis
by: Ahmed, Aisha Siddiqah
Published: (2012)

Enhancing Therapeutic Radiation Responses in Multiple Myeloma
by: Salem, Kelley, et al.
Published: (2012)

Thrombosis Associated with Immunomodulatory Agents in Multiple Myeloma
by: Gonzalez-Porras, Jose Ramon, et al.
Published: (2012)

The Ubiquitin-Proteasomal System and Blood Cancer Therapy
by: Mao, Xinliang, et al.
Published: (2012)

Pharmacovigilance and signal detection of adverse drug events associated with proteasome inhibitors in multiple myeloma: a real-world analysis using the FAERS database
by: JunYun Luo, et al.
Published: (2025-12-01)

The SUMOylation Pathway as a Potential Therapeutic Target in Multiple Myeloma
by: Driscoll, James J.
Published: (2012)

The Current Role of Stem Cell Transplantation in Multiple Myeloma
by: Gupta, Ajay
Published: (2012)

The Proteasome as a Therapeutic Target in Chronic Myeloid Leukemia
by: Pérez-Roger, Ignacio, et al.
Published: (2011)

Cellular Immunotherapy Using Dendritic Cells Against Multiple Myeloma
by: Lee, Je-Jung, et al.
Published: (2012)

Therapeutic Approaches for Targeting Hypoxia- Inducible Factor in Multiple Myeloma
by: Kirito, Keita
Published: (2012)

Chapter 8 The Contribution of Prognostic Factors to the Better Management of Multiple Myeloma Patients
by: Kyrtsonis, Marie-Christine, et al.
Published: (2012)

The Ubiquitin-Proteasome System and DNA Repair
by: Falaschetti, Christine A., et al.
Published: (2011)

Proteasome inhibitors: situation and prospects (literature review and own data)
by: A. A. Rukavitsyn, et al.
Published: (2016-10-01)

Treatment of double-refractory multiple myeloma
by: S. V. Semochkin
Published: (2021-09-01)

Results of multiple myeloma treatment with bortezomib
by: T. I. Pospelova, et al.
Published: (2022-11-01)

Review of the Expert Council “Multiple myeloma: the era of monoclonal antibodies in the treatment of patients with multiple myeloma”
by: M. I. Akhmedov, et al.
Published: (2024-01-01)

TREATMENT MANAGEMENT IN MULTIPLE MYELOMA WITH RENAL DISORDER
by: Meryem Sener
Published: (2025-07-01)

Treatment of bone complications in multiple myeloma patients
by: V. V. Ptushkin
Published: (2022-11-01)

Farnesyltransferase Inhibitor in Cancer Treatment
by: Agrawal, Anuj G., et al.
Published: (2011)

The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)

Topical Calcineurin Inhibitors in the Treatment of Vitiligo
by: Caridi, Cristina, et al.
Published: (2011)

Modern therapy of multiple myeloma
by: O. M. Votyakova
Published: (2008-12-01)

The role of Capon in multiple myeloma
by: Yaodong Shen, et al.
Published: (2017-06-01)

Multiple Myeloma with Intracranial Distribution
by: A. Yu. Rynda, et al.
Published: (2023-06-01)

Comorbidities in patients with multiple myeloma
by: L. P. Kuznetsova, et al.
Published: (2019-08-01)

Impact of treatment delay of multiple myeloma bone disease on later myeloma-related skeletal events and outcome
by: Eskelinen Veera, et al.
Published: (2025-08-01)

The Effects of Viscum album (Mistletoe) QuFrF Extract and Vincristine in Human Multiple Myeloma Cell Lines - A Comparative Experimental Study Using Several and Different Parameters
by: Kovacs, Eva
Published: (2012)

The multicenter experience with bendamustine in the treatment of relapsed and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2015-10-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
by: E. A. Senkina, et al.
Published: (2014-07-01)

Onset of multiple myeloma with rheumatic polymyalgia
by: E. R. Israelyan, et al.
Published: (2019-12-01)

Biological basis of immunomodulatory preparations using in treatment of multiple myeloma
by: S. V. Semochkin
Published: (2022-11-01)